Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP497538.RAW8LCnrF6K5b6GC8kaknZiYJNaDT_X61u18SE7UYg8z4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP497538.RAW8LCnrF6K5b6GC8kaknZiYJNaDT_X61u18SE7UYg8z4130_assertion type Assertion NP497538.RAW8LCnrF6K5b6GC8kaknZiYJNaDT_X61u18SE7UYg8z4130_head.
- NP497538.RAW8LCnrF6K5b6GC8kaknZiYJNaDT_X61u18SE7UYg8z4130_assertion description "[To evaluate whether DLC-1 could be a therapeutic target for non-Hodgkin lymphoma (NHL), we examined the expressions of DLC-1 in Burkitt's lymphoma (BL) cell lines and tested the effects of DLC-1 on cellular growth and migration in BL cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497538.RAW8LCnrF6K5b6GC8kaknZiYJNaDT_X61u18SE7UYg8z4130_provenance.
- NP497538.RAW8LCnrF6K5b6GC8kaknZiYJNaDT_X61u18SE7UYg8z4130_assertion evidence source_evidence_literature NP497538.RAW8LCnrF6K5b6GC8kaknZiYJNaDT_X61u18SE7UYg8z4130_provenance.
- NP497538.RAW8LCnrF6K5b6GC8kaknZiYJNaDT_X61u18SE7UYg8z4130_assertion SIO_000772 20882354 NP497538.RAW8LCnrF6K5b6GC8kaknZiYJNaDT_X61u18SE7UYg8z4130_provenance.
- NP497538.RAW8LCnrF6K5b6GC8kaknZiYJNaDT_X61u18SE7UYg8z4130_assertion wasDerivedFrom befree-20140225 NP497538.RAW8LCnrF6K5b6GC8kaknZiYJNaDT_X61u18SE7UYg8z4130_provenance.
- NP497538.RAW8LCnrF6K5b6GC8kaknZiYJNaDT_X61u18SE7UYg8z4130_assertion wasGeneratedBy ECO_0000203 NP497538.RAW8LCnrF6K5b6GC8kaknZiYJNaDT_X61u18SE7UYg8z4130_provenance.